nodes	percent_of_prediction	percent_of_DWPC	metapath
Pranlukast—ABCC2—Mycophenolate mofetil—systemic scleroderma	0.174	0.435	CbGbCtD
Pranlukast—CYP2C9—Leflunomide—systemic scleroderma	0.0943	0.237	CbGbCtD
Pranlukast—ABCC2—Methotrexate—systemic scleroderma	0.0696	0.175	CbGbCtD
Pranlukast—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.0339	0.0851	CbGbCtD
Pranlukast—CYP2C9—cardial valve—systemic scleroderma	0.0335	0.18	CbGeAlD
Pranlukast—CYP3A4—Prednisone—systemic scleroderma	0.0271	0.068	CbGbCtD
Pranlukast—IL5—connective tissue—systemic scleroderma	0.0175	0.0943	CbGeAlD
Pranlukast—RNASE3—digestive system—systemic scleroderma	0.0139	0.075	CbGeAlD
Pranlukast—MUC2—connective tissue—systemic scleroderma	0.0135	0.0725	CbGeAlD
Pranlukast—RNASE3—tendon—systemic scleroderma	0.0133	0.0714	CbGeAlD
Pranlukast—IL5—digestive system—systemic scleroderma	0.0126	0.0681	CbGeAlD
Pranlukast—RNASE3—lung—systemic scleroderma	0.0116	0.0626	CbGeAlD
Pranlukast—IL5—lung—systemic scleroderma	0.0106	0.0569	CbGeAlD
Pranlukast—MUC2—digestive system—systemic scleroderma	0.00973	0.0524	CbGeAlD
Pranlukast—MUC2—lung—systemic scleroderma	0.00812	0.0437	CbGeAlD
Pranlukast—NFKB1—connective tissue—systemic scleroderma	0.00768	0.0413	CbGeAlD
Pranlukast—CYSLTR1—smooth muscle tissue—systemic scleroderma	0.0069	0.0371	CbGeAlD
Pranlukast—NFKB1—digestive system—systemic scleroderma	0.00555	0.0299	CbGeAlD
Pranlukast—NFKB1—tendon—systemic scleroderma	0.00528	0.0284	CbGeAlD
Pranlukast—NFKB1—lung—systemic scleroderma	0.00463	0.0249	CbGeAlD
Pranlukast—CYSLTR1—lung—systemic scleroderma	0.00455	0.0245	CbGeAlD
Pranlukast—ABCC2—digestive system—systemic scleroderma	0.00218	0.0117	CbGeAlD
Pranlukast—ABCC2—tendon—systemic scleroderma	0.00207	0.0112	CbGeAlD
Pranlukast—CYP2C9—digestive system—systemic scleroderma	0.00145	0.00781	CbGeAlD
Pranlukast—NFKB1—TCR signaling—HLA-DQB1—systemic scleroderma	0.00119	0.00287	CbGpPWpGaD
Pranlukast—NFKB1—B Cell Receptor Signaling Pathway—BLK—systemic scleroderma	0.00119	0.00286	CbGpPWpGaD
Pranlukast—TNF—Spinal Cord Injury—TNFSF13—systemic scleroderma	0.00117	0.00282	CbGpPWpGaD
Pranlukast—TNF—Downstream signaling in naïve CD8+ T cells—STAT4—systemic scleroderma	0.00117	0.00282	CbGpPWpGaD
Pranlukast—IL5—Allograft Rejection—IL1B—systemic scleroderma	0.00115	0.00277	CbGpPWpGaD
Pranlukast—TNF—Apoptosis—IRF5—systemic scleroderma	0.00115	0.00276	CbGpPWpGaD
Pranlukast—NFKB1—IL1 and megakaryotyces in obesity—MMP9—systemic scleroderma	0.00114	0.00275	CbGpPWpGaD
Pranlukast—TNF—FAS pathway and Stress induction of HSP regulation—IL1A—systemic scleroderma	0.00113	0.00273	CbGpPWpGaD
Pranlukast—NFKB1—IL23-mediated signaling events—CCL2—systemic scleroderma	0.00113	0.00272	CbGpPWpGaD
Pranlukast—CYP3A4—digestive system—systemic scleroderma	0.00111	0.00595	CbGeAlD
Pranlukast—TNF—Allograft Rejection—IL13—systemic scleroderma	0.00109	0.00261	CbGpPWpGaD
Pranlukast—NFKB1—Toll Like Receptor 4 (TLR4) Cascade—ITGAM—systemic scleroderma	0.00107	0.00257	CbGpPWpGaD
Pranlukast—IL5—Hemostasis—SELP—systemic scleroderma	0.00106	0.00254	CbGpPWpGaD
Pranlukast—TNF—Spinal Cord Injury—SELP—systemic scleroderma	0.00105	0.00252	CbGpPWpGaD
Pranlukast—NFKB1—TWEAK Signaling Pathway—CCL2—systemic scleroderma	0.00102	0.00246	CbGpPWpGaD
Pranlukast—NFKB1—Regulation of toll-like receptor signaling pathway—IRF5—systemic scleroderma	0.00101	0.00242	CbGpPWpGaD
Pranlukast—TNF—Cellular roles of Anthrax toxin—IL1B—systemic scleroderma	0.000992	0.00239	CbGpPWpGaD
Pranlukast—IL5—AP-1 transcription factor network—TGFB1—systemic scleroderma	0.000986	0.00237	CbGpPWpGaD
Pranlukast—IL5—Hemostasis—RHOB—systemic scleroderma	0.000985	0.00237	CbGpPWpGaD
Pranlukast—TNF—Toll-like Receptor Signaling Pathway—IRF5—systemic scleroderma	0.000984	0.00237	CbGpPWpGaD
Pranlukast—TNF—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—systemic scleroderma	0.00098	0.00236	CbGpPWpGaD
Pranlukast—TNF—Spinal Cord Injury—RHOB—systemic scleroderma	0.000977	0.00235	CbGpPWpGaD
Pranlukast—TNF—Matrix Metalloproteinases—MMP2—systemic scleroderma	0.000971	0.00233	CbGpPWpGaD
Pranlukast—MUC2—Metabolism of proteins—ACE—systemic scleroderma	0.00097	0.00233	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—TOP1—systemic scleroderma	0.000964	0.00232	CbGpPWpGaD
Pranlukast—TNF—TNF alpha Signaling Pathway—TNFAIP3—systemic scleroderma	0.000956	0.0023	CbGpPWpGaD
Pranlukast—NFKB1—Toll-Like Receptors Cascades—ITGAM—systemic scleroderma	0.000953	0.00229	CbGpPWpGaD
Pranlukast—NFKB1—Osteopontin-mediated events—MMP9—systemic scleroderma	0.000933	0.00224	CbGpPWpGaD
Pranlukast—TNF—amb2 Integrin signaling—MMP2—systemic scleroderma	0.000922	0.00222	CbGpPWpGaD
Pranlukast—NFKB1—IL1-mediated signaling events—IL1B—systemic scleroderma	0.000919	0.00221	CbGpPWpGaD
Pranlukast—NFKB1—amb2 Integrin signaling—MMP9—systemic scleroderma	0.000909	0.00219	CbGpPWpGaD
Pranlukast—NFKB1—Regulation of toll-like receptor signaling pathway—TNFAIP3—systemic scleroderma	0.000902	0.00217	CbGpPWpGaD
Pranlukast—IL5—Hemostasis—CSK—systemic scleroderma	0.000897	0.00216	CbGpPWpGaD
Pranlukast—IL5—Signaling by Interleukins—IL1B—systemic scleroderma	0.000897	0.00216	CbGpPWpGaD
Pranlukast—IL5—Allograft Rejection—TGFB1—systemic scleroderma	0.000895	0.00215	CbGpPWpGaD
Pranlukast—NFKB1—Oncostatin M Signaling Pathway—MMP1—systemic scleroderma	0.000887	0.00213	CbGpPWpGaD
Pranlukast—NFKB1—Vitamin B12 Metabolism—CCL2—systemic scleroderma	0.000876	0.00211	CbGpPWpGaD
Pranlukast—TNF—Allograft Rejection—CTLA4—systemic scleroderma	0.000874	0.0021	CbGpPWpGaD
Pranlukast—TNF—IL27-mediated signaling events—IL1B—systemic scleroderma	0.000868	0.00209	CbGpPWpGaD
Pranlukast—TNF—IL23-mediated signaling events—CCL2—systemic scleroderma	0.000863	0.00207	CbGpPWpGaD
Pranlukast—NFKB1—MicroRNAs in cardiomyocyte hypertrophy—EDN1—systemic scleroderma	0.00086	0.00207	CbGpPWpGaD
Pranlukast—NFKB1—IL23-mediated signaling events—IL1B—systemic scleroderma	0.000859	0.00207	CbGpPWpGaD
Pranlukast—NFKB1—Angiopoietin receptor Tie2-mediated signaling—MMP2—systemic scleroderma	0.000847	0.00204	CbGpPWpGaD
Pranlukast—IL5—Cytokine Signaling in Immune system—HLA-DQB1—systemic scleroderma	0.000845	0.00203	CbGpPWpGaD
Pranlukast—IL5—Hemostasis—ITGAM—systemic scleroderma	0.000843	0.00203	CbGpPWpGaD
Pranlukast—TNF—Cytokines and Inflammatory Response—IL1B—systemic scleroderma	0.000842	0.00202	CbGpPWpGaD
Pranlukast—NFKB1—SIDS Susceptibility Pathways—IL13—systemic scleroderma	0.000828	0.00199	CbGpPWpGaD
Pranlukast—NFKB1—IL-1 signaling pathway—CCL2—systemic scleroderma	0.000825	0.00198	CbGpPWpGaD
Pranlukast—NFKB1—TCR Signaling Pathway—IL1A—systemic scleroderma	0.000809	0.00194	CbGpPWpGaD
Pranlukast—NFKB1—Interleukin-1 signaling—IL1B—systemic scleroderma	0.000807	0.00194	CbGpPWpGaD
Pranlukast—IL5—Cytokine Signaling in Immune system—IL1A—systemic scleroderma	0.000803	0.00193	CbGpPWpGaD
Pranlukast—CYSLTR1—G alpha (q) signalling events—EDN1—systemic scleroderma	0.0008	0.00192	CbGpPWpGaD
Pranlukast—NFKB1—Angiopoietin receptor Tie2-mediated signaling—NOS3—systemic scleroderma	0.000793	0.00191	CbGpPWpGaD
Pranlukast—TNF—TWEAK Signaling Pathway—CCL2—systemic scleroderma	0.00078	0.00187	CbGpPWpGaD
Pranlukast—TNF—Regulation of toll-like receptor signaling pathway—IRF5—systemic scleroderma	0.000768	0.00185	CbGpPWpGaD
Pranlukast—NFKB1—Glucocorticoid receptor regulatory network—MMP1—systemic scleroderma	0.000737	0.00177	CbGpPWpGaD
Pranlukast—TNF—Monoamine Transport—IL1B—systemic scleroderma	0.000735	0.00177	CbGpPWpGaD
Pranlukast—NFKB1—TWEAK Signaling Pathway—MMP9—systemic scleroderma	0.000732	0.00176	CbGpPWpGaD
Pranlukast—TNF—Matrix Metalloproteinases—MMP9—systemic scleroderma	0.00073	0.00175	CbGpPWpGaD
Pranlukast—NFKB1—Oncostatin M Signaling Pathway—CCL2—systemic scleroderma	0.000721	0.00173	CbGpPWpGaD
Pranlukast—TNF—Allograft Rejection—HLA-DQB1—systemic scleroderma	0.00072	0.00173	CbGpPWpGaD
Pranlukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—systemic scleroderma	0.000716	0.00172	CbGpPWpGaD
Pranlukast—NFKB1—Senescence-Associated Secretory Phenotype (SASP)—IL1A—systemic scleroderma	0.000715	0.00172	CbGpPWpGaD
Pranlukast—NFKB1—Folate Metabolism—CCL2—systemic scleroderma	0.000713	0.00171	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by Interleukins—IL1A—systemic scleroderma	0.000699	0.00168	CbGpPWpGaD
Pranlukast—NFKB1—LPA receptor mediated events—MMP2—systemic scleroderma	0.000695	0.00167	CbGpPWpGaD
Pranlukast—TNF—amb2 Integrin signaling—MMP9—systemic scleroderma	0.000693	0.00167	CbGpPWpGaD
Pranlukast—TNF—Regulation of toll-like receptor signaling pathway—TNFAIP3—systemic scleroderma	0.000687	0.00165	CbGpPWpGaD
Pranlukast—TNF—Allograft Rejection—IL1A—systemic scleroderma	0.000684	0.00164	CbGpPWpGaD
Pranlukast—NFKB1—B Cell Activation—BLK—systemic scleroderma	0.00068	0.00164	CbGpPWpGaD
Pranlukast—TNF—Allograft Rejection—CD40LG—systemic scleroderma	0.00068	0.00164	CbGpPWpGaD
Pranlukast—NFKB1—AGE/RAGE pathway—MMP2—systemic scleroderma	0.000678	0.00163	CbGpPWpGaD
Pranlukast—TNF—IL27-mediated signaling events—TGFB1—systemic scleroderma	0.000674	0.00162	CbGpPWpGaD
Pranlukast—TNF—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—systemic scleroderma	0.000674	0.00162	CbGpPWpGaD
Pranlukast—TNF—Vitamin B12 Metabolism—CCL2—systemic scleroderma	0.000667	0.0016	CbGpPWpGaD
Pranlukast—NFKB1—Vitamin B12 Metabolism—IL1B—systemic scleroderma	0.000664	0.0016	CbGpPWpGaD
Pranlukast—TNF—MicroRNAs in cardiomyocyte hypertrophy—EDN1—systemic scleroderma	0.000655	0.00158	CbGpPWpGaD
Pranlukast—TNF—IL23-mediated signaling events—IL1B—systemic scleroderma	0.000654	0.00157	CbGpPWpGaD
Pranlukast—TNF—Cytokines and Inflammatory Response—TGFB1—systemic scleroderma	0.000654	0.00157	CbGpPWpGaD
Pranlukast—TNF—Angiopoietin receptor Tie2-mediated signaling—MMP2—systemic scleroderma	0.000645	0.00155	CbGpPWpGaD
Pranlukast—NFKB1—AGE/RAGE pathway—NOS3—systemic scleroderma	0.000635	0.00153	CbGpPWpGaD
Pranlukast—TNF—SIDS Susceptibility Pathways—IL13—systemic scleroderma	0.000631	0.00152	CbGpPWpGaD
Pranlukast—NFKB1—IL-1 signaling pathway—IL1B—systemic scleroderma	0.000625	0.0015	CbGpPWpGaD
Pranlukast—MUC2—Metabolism of proteins—MMP1—systemic scleroderma	0.000623	0.0015	CbGpPWpGaD
Pranlukast—IL5—GPCR downstream signaling—RHOB—systemic scleroderma	0.000622	0.0015	CbGpPWpGaD
Pranlukast—TNF—Angiopoietin receptor Tie2-mediated signaling—NOS3—systemic scleroderma	0.000604	0.00145	CbGpPWpGaD
Pranlukast—NFKB1—IL12-mediated signaling events—IL1B—systemic scleroderma	0.000583	0.0014	CbGpPWpGaD
Pranlukast—NFKB1—Cytokine Signaling in Immune system—IRF5—systemic scleroderma	0.000576	0.00138	CbGpPWpGaD
Pranlukast—NFKB1—Leptin signaling pathway—NOS3—systemic scleroderma	0.000573	0.00138	CbGpPWpGaD
Pranlukast—NFKB1—Selenium Micronutrient Network—CCL2—systemic scleroderma	0.000566	0.00136	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—RHOB—systemic scleroderma	0.000565	0.00136	CbGpPWpGaD
Pranlukast—TNF—TWEAK Signaling Pathway—MMP9—systemic scleroderma	0.000557	0.00134	CbGpPWpGaD
Pranlukast—NFKB1—Cytokine Signaling in Immune system—IRF8—systemic scleroderma	0.00055	0.00132	CbGpPWpGaD
Pranlukast—TNF—Aryl Hydrocarbon Receptor Pathway—IL1B—systemic scleroderma	0.00055	0.00132	CbGpPWpGaD
Pranlukast—NFKB1—TNF alpha Signaling Pathway—CCL2—systemic scleroderma	0.000546	0.00131	CbGpPWpGaD
Pranlukast—TNF—Folate Metabolism—CCL2—systemic scleroderma	0.000543	0.00131	CbGpPWpGaD
Pranlukast—NFKB1—Folate Metabolism—IL1B—systemic scleroderma	0.000541	0.0013	CbGpPWpGaD
Pranlukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—EDN1—systemic scleroderma	0.00053	0.00127	CbGpPWpGaD
Pranlukast—NFKB1—LPA receptor mediated events—MMP9—systemic scleroderma	0.000522	0.00126	CbGpPWpGaD
Pranlukast—NFKB1—SIDS Susceptibility Pathways—IL1A—systemic scleroderma	0.000521	0.00125	CbGpPWpGaD
Pranlukast—NFKB1—AGE/RAGE pathway—MMP9—systemic scleroderma	0.00051	0.00123	CbGpPWpGaD
Pranlukast—MUC2—Metabolism of proteins—CCL2—systemic scleroderma	0.000507	0.00122	CbGpPWpGaD
Pranlukast—TNF—Vitamin B12 Metabolism—IL1B—systemic scleroderma	0.000506	0.00122	CbGpPWpGaD
Pranlukast—TNF—Spinal Cord Injury—IL1A—systemic scleroderma	0.000496	0.00119	CbGpPWpGaD
Pranlukast—NFKB1—TGF-beta Receptor Signaling—TGFB1—systemic scleroderma	0.000493	0.00119	CbGpPWpGaD
Pranlukast—NFKB1—MAPK Signaling Pathway—IL1A—systemic scleroderma	0.000491	0.00118	CbGpPWpGaD
Pranlukast—NFKB1—Leptin signaling pathway—IL1B—systemic scleroderma	0.000488	0.00117	CbGpPWpGaD
Pranlukast—NFKB1—Corticotropin-releasing hormone—NOS3—systemic scleroderma	0.000487	0.00117	CbGpPWpGaD
Pranlukast—NFKB1—Cardiac Hypertrophic Response—TGFB1—systemic scleroderma	0.000486	0.00117	CbGpPWpGaD
Pranlukast—MUC2—Metabolism of proteins—MMP2—systemic scleroderma	0.000482	0.00116	CbGpPWpGaD
Pranlukast—IL5—Immune System—CSK—systemic scleroderma	0.00047	0.00113	CbGpPWpGaD
Pranlukast—IL5—Immune System—IRF5—systemic scleroderma	0.000463	0.00111	CbGpPWpGaD
Pranlukast—NFKB1—Cellular Senescence—IL1A—systemic scleroderma	0.000452	0.00109	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Breast Cancer Pathway—MMP1—systemic scleroderma	0.000452	0.00109	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR downstream signaling—RHOB—systemic scleroderma	0.000447	0.00107	CbGpPWpGaD
Pranlukast—IL5—Immune System—IRF8—systemic scleroderma	0.000442	0.00106	CbGpPWpGaD
Pranlukast—IL5—Immune System—ITGAM—systemic scleroderma	0.000442	0.00106	CbGpPWpGaD
Pranlukast—IL5—Immune System—CD247—systemic scleroderma	0.000442	0.00106	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—SMAD7—systemic scleroderma	0.000432	0.00104	CbGpPWpGaD
Pranlukast—TNF—Selenium Micronutrient Network—CCL2—systemic scleroderma	0.000431	0.00104	CbGpPWpGaD
Pranlukast—NFKB1—Selenium Micronutrient Network—IL1B—systemic scleroderma	0.000429	0.00103	CbGpPWpGaD
Pranlukast—TNF—Aryl Hydrocarbon Receptor Pathway—TGFB1—systemic scleroderma	0.000427	0.00103	CbGpPWpGaD
Pranlukast—IL5—Hemostasis—MMP1—systemic scleroderma	0.000423	0.00102	CbGpPWpGaD
Pranlukast—NFKB1—TCR Signaling Pathway—IL1B—systemic scleroderma	0.000422	0.00101	CbGpPWpGaD
Pranlukast—IL5—Cytokine Signaling in Immune system—IL1B—systemic scleroderma	0.000419	0.00101	CbGpPWpGaD
Pranlukast—TNF—TNF alpha Signaling Pathway—CCL2—systemic scleroderma	0.000416	0.001	CbGpPWpGaD
Pranlukast—IL5—Immune System—TNFAIP3—systemic scleroderma	0.000414	0.000996	CbGpPWpGaD
Pranlukast—TNF—Folate Metabolism—IL1B—systemic scleroderma	0.000412	0.00099	CbGpPWpGaD
Pranlukast—NFKB1—Regulation of Telomerase—TGFB1—systemic scleroderma	0.00041	0.000986	CbGpPWpGaD
Pranlukast—IL5—Immune System—BLK—systemic scleroderma	0.000409	0.000984	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—RHOB—systemic scleroderma	0.000408	0.000981	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—RHOB—systemic scleroderma	0.000406	0.000976	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR ligand binding—EDN1—systemic scleroderma	0.000404	0.000971	CbGpPWpGaD
Pranlukast—TNF—SIDS Susceptibility Pathways—IL1A—systemic scleroderma	0.000397	0.000954	CbGpPWpGaD
Pranlukast—IL5—Platelet activation, signaling and aggregation—TGFB1—systemic scleroderma	0.000393	0.000945	CbGpPWpGaD
Pranlukast—NFKB1—Toll-like Receptor Signaling Pathway—IL1B—systemic scleroderma	0.000382	0.000918	CbGpPWpGaD
Pranlukast—TNF—TGF-beta Receptor Signaling—TGFB1—systemic scleroderma	0.000376	0.000904	CbGpPWpGaD
Pranlukast—TNF—MAPK Signaling Pathway—IL1A—systemic scleroderma	0.000374	0.000899	CbGpPWpGaD
Pranlukast—NFKB1—Transcriptional regulation of white adipocyte differentiation—TGFB1—systemic scleroderma	0.000371	0.000893	CbGpPWpGaD
Pranlukast—TNF—Cardiac Hypertrophic Response—TGFB1—systemic scleroderma	0.00037	0.00089	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by Interleukins—IL1B—systemic scleroderma	0.000365	0.000877	CbGpPWpGaD
Pranlukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—CCL2—systemic scleroderma	0.000362	0.000871	CbGpPWpGaD
Pranlukast—TNF—Allograft Rejection—IL1B—systemic scleroderma	0.000357	0.000858	CbGpPWpGaD
Pranlukast—TNF—Alzheimers Disease—IL1B—systemic scleroderma	0.000357	0.000858	CbGpPWpGaD
Pranlukast—NFKB1—MicroRNAs in cardiomyocyte hypertrophy—TGFB1—systemic scleroderma	0.000346	0.000833	CbGpPWpGaD
Pranlukast—NFKB1—Cytokine Signaling in Immune system—HLA-DQB1—systemic scleroderma	0.000343	0.000826	CbGpPWpGaD
Pranlukast—NFKB1—Cellular responses to stress—IL1A—systemic scleroderma	0.000342	0.000822	CbGpPWpGaD
Pranlukast—TNF—Spinal Cord Injury—CCL2—systemic scleroderma	0.000341	0.00082	CbGpPWpGaD
Pranlukast—IL5—Immune System—CTLA4—systemic scleroderma	0.000335	0.000806	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—RHOB—systemic scleroderma	0.000334	0.000803	CbGpPWpGaD
Pranlukast—NFKB1—TCR Signaling Pathway—TGFB1—systemic scleroderma	0.000328	0.000788	CbGpPWpGaD
Pranlukast—TNF—Selenium Micronutrient Network—IL1B—systemic scleroderma	0.000327	0.000787	CbGpPWpGaD
Pranlukast—NFKB1—Cytokine Signaling in Immune system—IL1A—systemic scleroderma	0.000326	0.000784	CbGpPWpGaD
Pranlukast—NFKB1—Corticotropin-releasing hormone—TGFB1—systemic scleroderma	0.000322	0.000774	CbGpPWpGaD
Pranlukast—NFKB1—Myometrial Relaxation and Contraction Pathways—NOS3—systemic scleroderma	0.000321	0.000772	CbGpPWpGaD
Pranlukast—IL5—GPCR downstream signaling—EDN1—systemic scleroderma	0.000318	0.000764	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—CSK—systemic scleroderma	0.000315	0.000758	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—HSPG2—systemic scleroderma	0.000315	0.000757	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—RHOB—systemic scleroderma	0.000311	0.000748	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—SMAD7—systemic scleroderma	0.00031	0.000745	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—ITGAM—systemic scleroderma	0.000309	0.000742	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—CD247—systemic scleroderma	0.000309	0.000742	CbGpPWpGaD
Pranlukast—IL5—Hemostasis—NOS3—systemic scleroderma	0.000306	0.000737	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—CSK—systemic scleroderma	0.000304	0.000731	CbGpPWpGaD
Pranlukast—NFKB1—Regulation of toll-like receptor signaling pathway—IL1B—systemic scleroderma	0.000298	0.000716	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—CD247—systemic scleroderma	0.000296	0.000713	CbGpPWpGaD
Pranlukast—TNF—Toll-like Receptor Signaling Pathway—IL1B—systemic scleroderma	0.000291	0.000699	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—TNFAIP3—systemic scleroderma	0.000289	0.000695	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—EDN1—systemic scleroderma	0.000289	0.000694	CbGpPWpGaD
Pranlukast—TNF—Transcriptional regulation of white adipocyte differentiation—TGFB1—systemic scleroderma	0.000283	0.00068	CbGpPWpGaD
Pranlukast—NFKB1—DNA Damage Response (only ATM dependent)—TGFB1—systemic scleroderma	0.000281	0.000676	CbGpPWpGaD
Pranlukast—TNF—Allograft Rejection—TGFB1—systemic scleroderma	0.000277	0.000666	CbGpPWpGaD
Pranlukast—IL5—Immune System—HLA-DQB1—systemic scleroderma	0.000276	0.000664	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR ligand binding—CCL2—systemic scleroderma	0.000276	0.000664	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—BLK—systemic scleroderma	0.000274	0.000659	CbGpPWpGaD
Pranlukast—NFKB1—Myometrial Relaxation and Contraction Pathways—IL1B—systemic scleroderma	0.000273	0.000657	CbGpPWpGaD
Pranlukast—NFKB1—SIDS Susceptibility Pathways—IL1B—systemic scleroderma	0.000272	0.000653	CbGpPWpGaD
Pranlukast—TNF—MicroRNAs in cardiomyocyte hypertrophy—TGFB1—systemic scleroderma	0.000264	0.000635	CbGpPWpGaD
Pranlukast—IL5—Immune System—IL1A—systemic scleroderma	0.000262	0.000631	CbGpPWpGaD
Pranlukast—IL5—Immune System—CD40LG—systemic scleroderma	0.000261	0.000627	CbGpPWpGaD
Pranlukast—TNF—Spinal Cord Injury—IL1B—systemic scleroderma	0.000259	0.000622	CbGpPWpGaD
Pranlukast—NFKB1—MAPK Signaling Pathway—IL1B—systemic scleroderma	0.000256	0.000616	CbGpPWpGaD
Pranlukast—TNF—Spinal Cord Injury—MMP9—systemic scleroderma	0.000244	0.000587	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—RHOB—systemic scleroderma	0.00024	0.000576	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR downstream signaling—EDN1—systemic scleroderma	0.000228	0.000549	CbGpPWpGaD
Pranlukast—TNF—Regulation of toll-like receptor signaling pathway—IL1B—systemic scleroderma	0.000227	0.000546	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—HSPG2—systemic scleroderma	0.000226	0.000544	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—CTLA4—systemic scleroderma	0.000225	0.00054	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—CSK—systemic scleroderma	0.000218	0.000525	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—EDN1—systemic scleroderma	0.000207	0.000498	CbGpPWpGaD
Pranlukast—TNF—SIDS Susceptibility Pathways—IL1B—systemic scleroderma	0.000207	0.000498	CbGpPWpGaD
Pranlukast—IL5—Hemostasis—TGFB1—systemic scleroderma	0.000203	0.000487	CbGpPWpGaD
Pranlukast—TNF—Spinal Cord Injury—TGFB1—systemic scleroderma	0.000201	0.000483	CbGpPWpGaD
Pranlukast—NFKB1—MAPK Signaling Pathway—TGFB1—systemic scleroderma	0.000199	0.000478	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—CCL2—systemic scleroderma	0.000197	0.000474	CbGpPWpGaD
Pranlukast—TNF—MAPK Signaling Pathway—IL1B—systemic scleroderma	0.000195	0.000469	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—CSK—systemic scleroderma	0.000191	0.00046	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—IRF5—systemic scleroderma	0.000188	0.000452	CbGpPWpGaD
Pranlukast—TNF—Adipogenesis—TGFB1—systemic scleroderma	0.000186	0.000447	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—HLA-DQB1—systemic scleroderma	0.000185	0.000445	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—ITGAM—systemic scleroderma	0.00018	0.000432	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—IRF8—systemic scleroderma	0.00018	0.000432	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—CD247—systemic scleroderma	0.00018	0.000432	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Pancreatic Cancer Pathway—TGFB1—systemic scleroderma	0.00018	0.000432	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—SMAD7—systemic scleroderma	0.000175	0.000422	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—CD40LG—systemic scleroderma	0.000175	0.00042	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—EDN1—systemic scleroderma	0.000171	0.00041	CbGpPWpGaD
Pranlukast—NFKB1—Cytokine Signaling in Immune system—IL1B—systemic scleroderma	0.00017	0.000409	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—TNFAIP3—systemic scleroderma	0.000168	0.000405	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—BLK—systemic scleroderma	0.000166	0.0004	CbGpPWpGaD
Pranlukast—ABCC2—NRF2 pathway—TGFB1—systemic scleroderma	0.000158	0.00038	CbGpPWpGaD
Pranlukast—TNF—MAPK Signaling Pathway—TGFB1—systemic scleroderma	0.000152	0.000364	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—CCL2—systemic scleroderma	0.000142	0.000341	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—TGFB1—systemic scleroderma	0.000137	0.000329	CbGpPWpGaD
Pranlukast—IL5—Immune System—IL1B—systemic scleroderma	0.000137	0.000329	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—CTLA4—systemic scleroderma	0.000136	0.000328	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—RHOB—systemic scleroderma	0.000136	0.000326	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—MMP2—systemic scleroderma	0.000135	0.000326	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—HSPG2—systemic scleroderma	0.000128	0.000308	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—CSK—systemic scleroderma	0.000124	0.000297	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—EDN1—systemic scleroderma	0.000122	0.000294	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—CCL2—systemic scleroderma	0.000117	0.00028	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—HLA-DQB1—systemic scleroderma	0.000112	0.00027	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—HSPG2—systemic scleroderma	0.000107	0.000258	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—IL1A—systemic scleroderma	0.000107	0.000256	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—CD40LG—systemic scleroderma	0.000106	0.000255	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—NOS3—systemic scleroderma	0.000104	0.00025	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—MMP2—systemic scleroderma	0.000103	0.000248	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—MMP9—systemic scleroderma	0.000102	0.000245	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—TGFB1—systemic scleroderma	8.39e-05	0.000202	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—CCL2—systemic scleroderma	8.36e-05	0.000201	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—MMP9—systemic scleroderma	8.33e-05	0.0002	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—systemic scleroderma	8.13e-05	0.000195	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—MMP9—systemic scleroderma	7.76e-05	0.000187	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—NOS3—systemic scleroderma	7.46e-05	0.000179	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—EDN1—systemic scleroderma	6.93e-05	0.000167	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—TGFB1—systemic scleroderma	6.87e-05	0.000165	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—TGFB1—systemic scleroderma	6.39e-05	0.000154	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—MMP9—systemic scleroderma	5.98e-05	0.000144	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—IL1B—systemic scleroderma	5.56e-05	0.000134	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—TGFB1—systemic scleroderma	4.93e-05	0.000119	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—HSPG2—systemic scleroderma	4.78e-05	0.000115	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—CCL2—systemic scleroderma	4.74e-05	0.000114	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—NOS3—systemic scleroderma	4.22e-05	0.000102	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—CTGF—systemic scleroderma	3.62e-05	8.7e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—MMP9—systemic scleroderma	3.39e-05	8.15e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—HSPG2—systemic scleroderma	3.15e-05	7.57e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—TGFB1—systemic scleroderma	2.79e-05	6.71e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—CTGF—systemic scleroderma	2.39e-05	5.74e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—NOS3—systemic scleroderma	1.58e-05	3.79e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—NOS3—systemic scleroderma	1.04e-05	2.5e-05	CbGpPWpGaD
